Company / Operating Margin
Enveric Biosciences, Inc. Operating Margin History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-16.6%
FY2019
5-year range
-22.4% / -14.9%
FY2017-FY2019
Trend
+25.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -14.9% to -16.6% over the past 2 years.
Based on SEC 10-K filings.
-16.6% in FY2019.
Declined from -14.9% to -16.6% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, operating margin increased 25.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | -16.6% | +25.9% |
| FY2018 | -22.4% | -50.7% |
| FY2017 | -14.9% | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026